The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
SIRT in 2025
Cardiovasc Intervent Radiol. 2022 Nov;45(11):1622-1633.doi: 10.1007/s00270-022-03228-6. Epub 2022 Aug 8.
1Dipartimento di Scienze Mediche e Chirurgiche, U.O.C. Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario, A. Gemelli IRCCS, L.go A. Gemelli 8, 00168, Rome, Italy.
2Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia-U.O.C. Radiologia Diagnostica e Interventistica Generale, Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go A. F.Vito 1 Gemelli 8, 00168, Rome, Italy.
3Università Cattolica del Sacro Cuore, L.go A. Gemelli 8, 00168, Rome, Italy.
4Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia-U.O.C. Radiologia Diagnostica e Interventistica Generale, Fondazione Policlinico Universitario A. Gemelli IRCCS, L.go A. F.Vito 1 Gemelli 8, 00168, Rome, Italy. roberto.iezzi@unicatt.it.
5Università Cattolica del Sacro Cuore, L.go A. Gemelli 8, 00168, Rome, Italy. roberto.iezzi@unicatt.it.
#Contributed equally.
Abstract
Selective internal radiation therapy represents an endovascular treatment option for patients with primary liver malignancies, in different clinical stages. Potential applications of this treatment are in early-stage hepatocellular carcinoma, as a curative option, or in combination with systemic treatments in intermediate and advanced-stages. This review, based on existing literature and ongoing trials, will focus on the future of this treatment in patients with hepatocellular carcinoma, in combination with systemic treatments, or with the use of new devices and technological developments; it will also describe new potential future indications and structural and organizational perspectives.